magnesium L-lactate
magnesium, bis((2S)-2-(hydroxy-kappao)propanoato-kappao)-, (t-4)-
Identification
| Name | magnesium L-lactate |
| CAS Number | 862886-19-9 |
| FDA UNII | PE152PYI6M |
| Molecular Formula | C3 H5 Mg O3 |
| Molecular Weight | 113.37545000 |
Regulatory
Physical Properties
| Appearance | white powder (est) |
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | special dietary and nutritional additives |
| Recommendation for magnesium L-lactate usage levels up to | not for fragrance use. |
| Recommendation for magnesium L-lactate flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
magnesium laevo-lactate
magnesium, bis((2S)-2-(hydroxy-kappao)propanoato-kappao)-, (t-4)-
magnesium;(2S)-2-hydroxypropanoate
PubMed:
Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator.
PubMed:
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.